Clinical characteristics of KCNQ2 encephalopathy
- Authors
- Kim, H.J.; Yang, D.; Kim, S.H.; Won, D.; Kim, H.D.; Lee, J.S.; Choi, J.R.; Lee, S.-T.; Kang, H.-C.
- Issue Date
- Feb-2021
- Publisher
- ELSEVIER
- Keywords
- KCNQ2 encephalopathy; Neonatal seizures; Ohtahara syndrome; Sodium channel blockers
- Citation
- BRAIN & DEVELOPMENT, v.43, no.2, pp.244 - 250
- Journal Title
- BRAIN & DEVELOPMENT
- Volume
- 43
- Number
- 2
- Start Page
- 244
- End Page
- 250
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79917
- DOI
- 10.1016/j.braindev.2020.08.015
- ISSN
- 0387-7604
- Abstract
- Purpose: KCNQ2 mutations are associated with benign familial neonatal epilepsy (BFNE) or developmental and epileptic encephalopathy (DEE). In this study, we aimed to delineate the phenotype of KCNQ2 encephalopathy and evaluate the treatment response. Methods: Thirteen patients of KCNQ2 encephalopathy were included in the study. Characteristics of KCNQ2 mutations, electroclinical features, clinical course, and response to the treatment were analyzed. Results: Age range of the thirteen patients was between 3 months and 20.9 years. The onset of seizures in 11 patients ranged from 1 to 3 days of age, while in the other two patients it was 7 and 40 days, respectively. Most common initial seizure types were tonic seizures. Initial EEGs were suppression burst pattern in seven patients and slow and disorganized background with multifocal epileptiform discharges in six patients. Initial epilepsy syndrome was Ohtahara syndrome in seven patients, neonatal focal seizure in five patients, and focal epilepsy beyond neonatal period in one patient. Sodium channel blockers including oxcarbazepine (OXC) (n = 3), lamotrigine (LTG) (n = 3), phenytoin (PHT) (n = 2), topiramate (TPM) (n = 2), and zonisamide (ZNS) (n = 1) were tried and found effective in eleven patients. Ultimately, 12 of 13 patients became seizure-free. However, developmental outcomes were poor. Conclusions: Sodium channel blockers are effective in seizure control in these patients with KCNQ2 encephalopathy. Early recognition of KCNQ2 encephalopathy and early use of sodium channel blockers might be helpful in seizure control. © 2020 The Japanese Society of Child Neurology
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79917)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.